3-(6-(4-bromophenyl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazin-3-yl)-2H-chromen-2-one

ID: ALA4539544

Chembl Id: CHEMBL4539544

PubChem CID: 10320948

Max Phase: Preclinical

Molecular Formula: C19H11BrN4O2S

Molecular Weight: 439.29

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  O=c1oc2ccccc2cc1-c1nnc2n1N=C(c1ccc(Br)cc1)CS2

Standard InChI:  InChI=1S/C19H11BrN4O2S/c20-13-7-5-11(6-8-13)15-10-27-19-22-21-17(24(19)23-15)14-9-12-3-1-2-4-16(12)26-18(14)25/h1-9H,10H2

Standard InChI Key:  JWEIIYKTDJMIOB-UHFFFAOYSA-N

Associated Targets(Human)

NCI-H157 (619 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

BHK-21 (725 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 439.29Molecular Weight (Monoisotopic): 437.9786AlogP: 4.17#Rotatable Bonds: 2
Polar Surface Area: 73.28Molecular Species: NEUTRALHBA: 7HBD:
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 3.54CX LogD: 3.54
Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.44Np Likeness Score: -1.26

References

1. Zhang L, Xu Z..  (2019)  Coumarin-containing hybrids and their anticancer activities.,  181  [PMID:31404864] [10.1016/j.ejmech.2019.111587]

Source